Join the Oncology Voice Network. Join for Free
Why and How MSLs Can Adapt the Mindset of a Lifelong Learner
lifelong learning for MSLs personal accountability in learning engaging with KOLs platforms for MSL learning social media for professional growth

Why and How MSLs Can Adapt the Mindset of a Lifelong Learner


Share This Article


Summary

In this episode, Sarah Snyder shares her insights on lifelong learning for MSLs, emphasizing the importance of personal accountability and balancing different learning types. She discusses strategies for managing decision fatigue and setting achievable learning goals, providing valuable resources and book recommendations. Sarah encourages starting before feeling fully ready and highlights the significance of performance tracking. The conversation delves into engaging with KOLs and the potential of platforms like Clubhouse and TikTok for MSLs. Sarah concludes with advice on using social media strategically for professional growth, urging listeners to take action in their learning journey.

Sarah Snyder, Associate Director, Medical Affairs at Biosplice Therapeutics discusses why it is so important for MSLs to be lifelong learners.

Sarah shares…

πŸ‘‰ How to apply your learning style for success

πŸ‘‰ Resources and platforms that may be effective for MSL learning

πŸ‘‰ Why personal development can be as important as scientific learnings

πŸ‘‰ Her personal recommendations on recent books, podcasts, etc.

πŸ‘‰ How to tie personal development to performance

Click for Source
lifelong learning for MSLs, personal accountability in learning, engaging with KOLs, platforms for MSL learning, social media for professional growth

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?
OVN Avatar Omer Ben‐Aharon, Racheli Magnezi, Moshe Leshno, and Daniel A. Goldstein

Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?

Press Release
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
OVN Avatar OVN Staff

Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes

Press Release
Introducing OncologyVoiceNetwork.com
OVN Avatar OVN Staff

Introducing OncologyVoiceNetwork.com

Article
Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020
OVN Avatar A. Haslam, M.S. Kim, V. Prasad

Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Podcast
The Ideal Roadmap for New MSLs
Partner Avatar MSL Talk: Tom Caravela, Sarah Snyder

The Ideal Roadmap for New MSLs

Article
Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring
OVN Avatar B. Gyawali, E. G. E. de Vries, U. Dafni, T. Amaral, J. Barriuso, J. Bogaerts, A. Calles, G. Curigliano, C. Gomez-Roca, B. Kiesewetter, S. Oosting, A. Passaro, G. Pentheroudakis, M. Piccart, F. Roitberg, J. Tabernero, N. Tarazona, D. Trapani, R. Wester, G.

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring

Explore OVN